Build Back Better

Build Back Better

Do The Benefits Outweigh The Risks?

FDA Advisor Paul Offit Was Not Happy With The Latest "Booster" Decision

Mathew Aldred's avatar
Mathew Aldred
Jul 18, 2022
∙ Paid

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Mathew Aldred · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture